- Home
- DGII vs VERA Comparison
DGII vs VERA Comparison
Compare DGII & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGII
- VERA
- Stock Information
- Founded
- DGII 1985
- VERA 2016
- Country
- DGII United States
- VERA United States
- Employees
- DGII N/A
- VERA N/A
- Industry
- DGII Computer peripheral equipment
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- DGII Technology
- VERA Health Care
- Exchange
- DGII Nasdaq
- VERA Nasdaq
- Market Cap
- DGII 1.3B
- VERA 1.4B
- IPO Year
- DGII N/A
- VERA 2021
- Fundamental
- Price
- DGII $36.27
- VERA $24.82
- Analyst Decision
- DGII Buy
- VERA Buy
- Analyst Count
- DGII 4
- VERA 8
- Target Price
- DGII $38.75
- VERA $64.29
- AVG Volume (30 Days)
- DGII 198.6K
- VERA 1.8M
- Earning Date
- DGII 11-12-2025
- VERA 11-06-2025
- Dividend Yield
- DGII N/A
- VERA N/A
- EPS Growth
- DGII 147.46
- VERA N/A
- EPS
- DGII 1.14
- VERA N/A
- Revenue
- DGII $420,935,000.00
- VERA N/A
- Revenue This Year
- DGII $2.46
- VERA N/A
- Revenue Next Year
- DGII $7.77
- VERA N/A
- P/E Ratio
- DGII $31.36
- VERA N/A
- Revenue Growth
- DGII N/A
- VERA N/A
- 52 Week Low
- DGII $22.39
- VERA $18.53
- 52 Week High
- DGII $37.07
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- DGII 61.22
- VERA 60.70
- Support Level
- DGII $35.01
- VERA $22.72
- Resistance Level
- DGII $36.94
- VERA $25.29
- Average True Range (ATR)
- DGII 1.00
- VERA 1.15
- MACD
- DGII 0.18
- VERA 0.15
- Stochastic Oscillator
- DGII 80.88
- VERA 88.51
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.